HERE FOR 20 YEARS FOR PEOPLE WITH AN INTEREST IN MULTIPLE SCLEROSIS Skip to content

(Abst.) Real-world safety and effectiveness of ofatumumab in MS:...

145 Views 0 Replies

0 Members and 1 Guest are viewing this topic.

#1
From PubMed (February 27, 2026)--"Real-world safety and effectiveness of ofatumumab in multiple sclerosis:  A clinic-based study in Australia":


This study demonstrates high effectiveness of ofatumumab in an older RRMS population with longer disease duration than pivotal trials. A positive effect on PIRA was observed in 66.7% of those exper...
PubMed · pubmed.ncbi.nlm.nih.gov
MS Speaks--online for 20 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week)  12/16/20 - 3/16/24.